Skip to main content

Table 2 Summary of patient characteristics and CyberKnife radiotherapy parameters

From: Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series

Patient No.

Gender

Age (yrs)

CKRT regimen

Tumor volume (cm3)

Number of fractions

Prescription dose (Gy)

Dose per fraction (Gy)

Maximum dose (Gy)

Prescription isodose (%)

Conformality index

Heterogeneity index

Lesion coverage

Total No. of beams

1

F

47

SRS

3.14

1

15

15

18.52

81%

1.1

1.23

95.30%

190

2

F

72

SRS

6.97

1

15

15

18.29

82%

1.29

1.22

94.60%

230

3

M

57

SRS

8.76

1

13

13

17.33

75%

1.38

1.33

98.80%

262

4

F

75

SRS

0.52

1

13

13

18.57

70%

1.38

1.43

96.95%

150

5

M

71

SRS

3.46

1

18

18

24

75%

1.17

1.33

95.84%

125

6

F

86

HSRT

11.91

3

24

8

30

80%

1.51

1.25

97.43%

268

7

F

79

HSRT

3.73

5

30

6

35.71

84%

1.28

1.19

96.34%

190

8

F

84

HSRT

42.39

5

30

6

36.59

82%

1.22

1.22

95.16%

250

9

F

84

HSRT

10.12

5

30

6

37.97

79%

1.53

1.27

95.01%

209

10

F

63

HSRT

0.44

5

25

5

32.89

76%

1.77

1.32

93.48%

91

11

M

88

HSRT

11.35

5

25

5

33.33

75%

1.26

1.33

92.69%

157

12

M

60

FSRT

2.41

25

50

2

55.56

90%

1.95

1.11

95.35%

143

13

F

60

FSRT

0.32

28

50.4

1.8

60.72

83%

1.65

1.2

96.65%

180